Testosterone replacement therapy and cardiovascular risk: TRAVERSE with caution

By sjmartinez • July 21, 2024

Krishnan S, Aldana-Bitar J, Golub I, Kianoush S, Benzing T, Ichikawa K, Budoff MJ. Testosterone replacement therapy and cardiovascular risk: TRAVERSE with caution. Prog Cardiovasc Dis. 2024 Jul 17:S0033-0620(24)00100-2. doi: 10.1016/j.pcad.2024.07.003. Epub ahead of print. PMID: 39029567.

Tags: cardiovascular disease, Clinical Nutrition, General Internal Medicine, Harbor UCLA, meta-analysis, Publications, Resident, Testosterone replacement therapy, TRAVERSE trial

Response to the Letter to the Editor by Bett et al

Almandoz JP, Wadden TA, Tewksbury C, Apovian CM, Fitch A, Ard JD, Li Z, Richards J, Butsch WS, Jouravskaya I, Vanderman KS, Neff LM. Response[...]

Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity

Mechanick JI, Butsch WS, Christensen SM, Hamdy O, Li Z, Prado CM, Heymsfield SB. Strategies for minimizing muscle loss during use of incretin-mimetic drugs for[...]

Bariatric-induced microbiome changes alter MASLD development in association with changes in the innate immune system

Shera S, Katzka W, Yang JC, Chang C, Arias-Jayo N, Lagishetty V, Balioukova A, Chen Y, Dutson E, Li Z, Mayer EA, Pisegna JR, Sanmiguel[...]